XAMS
BSGR
Market cap561mUSD
Dec 22, Last price
5.85EUR
Name
B&S Group SA
Chart & performance
P/E
12.33
P/S
0.20
EPS
0.47
Div yield, %
2.74%
Shrs. gr., 5y
0.18%
Rev. gr., 5y
4.08%
Revenues
2.42b
+8.88%
Net income
40m
+18.28%
CFO
30m
-62.68%
Dividend
Apr 29, 20250.19 EUR/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
B&S Group S.A. operates as a global purveyor of a wide array of consumer products. The company structures its extensive operations across six distinct divisions: B&S Liquors, B&S Beauty, B&S Personal Care, B&S Food, B&S Health, and B&S Retail. The B&S Liquors segment is responsible for distributing branded alcoholic beverages to a client base that includes wholesalers, individual consumers, and e-commerce platforms. Likewise, the B&S Beauty division handles the distribution and sales of branded fragrances and cosmetics, reaching similar wholesale, direct-to-consumer, and digital channels. Branded personal and home care products are distributed and sold by the B&S Personal Care segment, primarily catering to retailers. The B&S Food segment supplies a diverse range of branded food and beverage items to specialized markets such as duty-free outlets, remote regions, conventional retail, and the maritime industry. In the healthcare sector, the B&S Health division provides branded medical goods and equipment to maritime and remote locations, alongside pharmacies and travel clinics. Lastly, B&S Retail manages a network of physical stores, predominantly located in international and regional airports and other 'away from home' venues, offering consumer electronics and a varied assortment of merchandise. Complementing its distribution efforts, the company also delivers comprehensive solutions in areas like sourcing, warehousing, logistics, digital commerce, marketing, and brand development. Established in 2007, B&S Group S.A. is headquartered in Betzdorf, Luxembourg.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||